{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:37:59Z","timestamp":1777606679323,"version":"3.51.4"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","award":["2023AH050649"],"award-info":[{"award-number":["2023AH050649"]}],"id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102432"],"award-info":[{"award-number":["82102432"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Provincial Natural Science Foundation Project","award":["2108085QH347"],"award-info":[{"award-number":["2108085QH347"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05315-8","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:02:53Z","timestamp":1742958173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Coinfection of COVID-19 and malaria: clinical profiles, interactions, and strategies for effective control"],"prefix":"10.1186","volume":"24","author":[{"given":"Mu-Zi","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Qun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"5315_CR1","unstructured":"WHO. Coronavirus (COVID-19) dashboard. Geneva: World Health Organization. 2024. https:\/\/covid19.who.int\/. Accessed 8 May 2024."},{"key":"5315_CR2","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240040496. Accessed 8 May 2024."},{"key":"5315_CR3","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization, 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240086173. Accessed 8 May 2024."},{"key":"5315_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100103","volume":"6","author":"A Ullrich","year":"2021","unstructured":"Ullrich A, Schranz M, Rexroth U, Hamouda O, Schaade L, Diercke M, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: an analysis of national surveillance data during week 1\u20132016\u2013week 32\u20132020. Lancet Reg Health Eur. 2021;6: 100103.","journal-title":"Lancet Reg Health Eur"},{"key":"5315_CR5","doi-asserted-by":"publisher","first-page":"taaa180","DOI":"10.1093\/jtm\/taaa180","volume":"27","author":"R Steffen","year":"2020","unstructured":"Steffen R, Lautenschlager S, Fehr J. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland. J Travel Med. 2020;27:taaa180.","journal-title":"J Travel Med"},{"key":"5315_CR6","doi-asserted-by":"publisher","first-page":"taaac083","DOI":"10.1093\/jtm\/taac083","volume":"29","author":"FF Norman","year":"2022","unstructured":"Norman FF, Trevi\u00f1o-Maruri B, Ruiz Giard\u00edn JM, Gull\u00f3n-Pe\u00f1a B, Salvador F, Serre N, et al. Trends in imported malaria during the COVID-19 pandemic, Spain (+Redivi collaborative network). J Travel Med. 2022;29:taaac083.","journal-title":"J Travel Med"},{"key":"5315_CR7","unstructured":"WHO. Malaria. Geneva: World Health Organization. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria. Accessed 10 June 2023."},{"key":"5315_CR8","first-page":"35","volume":"46","author":"AM Ahmad Saleh","year":"2016","unstructured":"Ahmad Saleh AM, Adam SM, Ibrahim AM, Morsy TA. Malaria: a general minireview with reference to Egypt. J Egypt Soc Parasitol. 2016;46:35\u201348.","journal-title":"J Egypt Soc Parasitol"},{"key":"5315_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2022.12366","volume":"328","author":"JP Daily","year":"2022","unstructured":"Daily JP, Minuti A, Khan N. Diagnosis, treatment, and prevention of malaria in the US: a review. JAMA. 2022;328:460\u201371.","journal-title":"JAMA"},{"key":"5315_CR10","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(23)01249-7","volume":"402","author":"JR Poespoprodjo","year":"2023","unstructured":"Poespoprodjo JR, Douglas NM, Ansong D, Kho S, Anstey NM. Malaria. Lancet. 2023;402:2328\u201345.","journal-title":"Lancet"},{"key":"5315_CR11","volume":"7","author":"MJ Correia","year":"2020","unstructured":"Correia MJ, Frade L, Guerreiro R, Araujo I, Baptista T, Fonseca C, et al. A patient with severe malaria and COVID-19: how do you tell the difference between these infections? Eur J Case Rep Intern Med. 2020;7: 002007.","journal-title":"Eur J Case Rep Intern Med"},{"key":"5315_CR12","volume":"13","author":"C Brebnor Des Isles","year":"2021","unstructured":"Brebnor Des Isles C, Chitrakar A, Patel H, Finney M. Blackwater fever in pregnancy with severe falciparum malaria: a case of imported malaria from Nigeria to the United Kingdom during the COVID-19 pandemic. Cureus. 2021;13: e20170.","journal-title":"Cureus"},{"key":"5315_CR13","unstructured":"Xuzhou Center for Disease Control and Prevention. Malaria communication-a person in severe coma! symptoms like \u201ctwo positive\u201d are easily misdiagnosed. China, Xuzhou Center for Disease Control and Prevention. 2023. https:\/\/www.xzcdc.com\/jkxx\/17583.html. Accessed 10 June 2023."},{"key":"5315_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n436","volume":"372","author":"AH Attaway","year":"2021","unstructured":"Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipo\u011flu U. Severe COVID-19 pneumonia: pathogenesis and clinical management. BMJ. 2021;372: n436.","journal-title":"BMJ"},{"key":"5315_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jinf.2016.02.001","volume":"72","author":"DG Lalloo","year":"2016","unstructured":"Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL. UK malaria treatment guidelines 2016. J Infect. 2016;72:635\u201349.","journal-title":"J Infect"},{"key":"5315_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/22221751.2021.1898291","volume":"10","author":"KK To","year":"2021","unstructured":"To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, et al. Lessons learned 1\u00a0year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microb Infect. 2021;10:507\u201335.","journal-title":"Emerg Microb Infect"},{"key":"5315_CR17","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/S2666-5247(21)00240-8","volume":"3","author":"J Achan","year":"2022","unstructured":"Achan J, Serwanga A, Wanzira H, Kyagulanyi T, Nuwa A, Magumba G, et al. Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda. Lancet Microb. 2022;3:e62\u201371.","journal-title":"Lancet Microb"},{"key":"5315_CR18","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1002\/jmv.27771","volume":"94","author":"KAHM Ahmed","year":"2022","unstructured":"Ahmed KAHM, Hasabo EA, Haroun MS, Eljack MMF, Salih EH, Altayeb YFO, et al. Clinical characteristics, complications, and predictors of outcome of hospitalized adult Sudanese patients with COVID-19 and malaria coinfection in Sudan: a multicenter retrospective cross-sectional study. J Med Virol. 2022;94:3685\u201397.","journal-title":"J Med Virol"},{"key":"5315_CR19","doi-asserted-by":"publisher","first-page":"1152.e1151","DOI":"10.1016\/j.cmi.2022.03.028","volume":"28","author":"R Hussein","year":"2022","unstructured":"Hussein R, Guedes M, Ibraheim N, Ali MM, El-Tahir A, Allam N, et al. Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort study. Clin Microbiol Infect. 2022;28:1152.e1151-1152.e1156.","journal-title":"Clin Microbiol Infect"},{"key":"5315_CR20","doi-asserted-by":"publisher","first-page":"8829848","DOI":"10.1155\/2020\/8829848","volume":"2020","author":"EO Onosakponome","year":"2020","unstructured":"Onosakponome EO, Wogu MN. The role of sex in Malaria-COVID-19 coinfection and some associated factors in Rivers State, Nigeria. J Parasitol Res. 2020;2020:8829848.","journal-title":"J Parasitol Res"},{"key":"5315_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5322","volume":"10","author":"YA Abdalla","year":"2022","unstructured":"Abdalla YA, Shaban AAM, Ahmed AHM, Haroun MS, Eljack MMF, Eltom KS, et al. Bilateral basal ganglia infarction and bilateral thalamic lesions in Sudanese pediatric patient with COVID-19 and malaria co-infection, a case report. Clin Case Rep. 2022;10: e05322.","journal-title":"Clin Case Rep"},{"key":"5315_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.828447","volume":"13","author":"H Zhu","year":"2022","unstructured":"Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X, et al. Interleukins and Ischemic Stroke. Front Immunol. 2022;13: 828447.","journal-title":"Front Immunol"},{"key":"5315_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13052-022-01311-9","volume":"48","author":"M Scalisi","year":"2022","unstructured":"Scalisi M, Giordano S, Canduscio LA, Failla MC, Messina L, Sferrazza E, et al. MIS-C and co-infection with P. vivax and P. falciparum in a child: a clinical conundrum. Ital J Pediatr. 2022;48:130.","journal-title":"Ital J Pediatr"},{"key":"5315_CR24","first-page":"73","volume":"24","author":"Z Mansoor","year":"2024","unstructured":"Mansoor Z, Nugud A, Abuhammour W, Yavuz L, Belt E, Sharif E. From multisystem inflammatory syndrome in children to secondary hemophagocytic lymphohistiocytosis a series of misfortunate events: case report and review of literature. Sudan J Paediatr. 2024;24:73\u20139.","journal-title":"Sudan J Paediatr"},{"key":"5315_CR25","unstructured":"WHO. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Geneva: World Health Organization. 2020. https:\/\/www.who.int\/publications\/i\/item\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed 1 June 2023."},{"key":"5315_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/tropicalmed7080145","volume":"7","author":"P Boonyarangka","year":"2022","unstructured":"Boonyarangka P, Phontham K, Sriwichai S, Poramathikul K, Harncharoenkul K, Kuntawunginn W, et al. Co-infection with Plasmodium vivax and COVID-19 in Thailand. Trop Med Infect Dis. 2022;7:145.","journal-title":"Trop Med Infect Dis"},{"key":"5315_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12098-020-03441-6","volume":"87","author":"R Kishore","year":"2020","unstructured":"Kishore R, Dhakad S, Arif N, Dar L, Mirdha BR, Aggarwal R, et al. COVID-19: possible cause of induction of relapse of Plasmodium vivax infection. Indian J Pediatr. 2020;87:751\u20132.","journal-title":"Indian J Pediatr"},{"key":"5315_CR28","first-page":"77","volume":"12","author":"Z Shahid","year":"2021","unstructured":"Shahid Z, Karim N, Shahid F, Yousaf Z. COVID-19 associated imported Plasmodium vivax malaria relapse: first reported case and literature review. Res Rep Trop Med. 2021;12:77\u201380.","journal-title":"Res Rep Trop Med"},{"key":"5315_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12936-022-04215-5","volume":"21","author":"TP Asmarawati","year":"2022","unstructured":"Asmarawati TP, Martani OS, Bramantono B, Arfijanto MV. Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report. Malar J. 2022;21:199.","journal-title":"Malar J"},{"key":"5315_CR30","first-page":"CD013639","volume":"5","author":"S Ebrahimzadeh","year":"2022","unstructured":"Ebrahimzadeh S, Islam N, Dawit H, Salameh JP, Kazi S, Fabiano N, et al. Thoracic imaging tests for the diagnosis of COVID-19. Cochrane Database Syst Rev. 2022;5:CD013639.","journal-title":"Cochrane Database Syst Rev"},{"key":"5315_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112752","volume":"172","author":"M Y\u00fcce","year":"2021","unstructured":"Y\u00fcce M, Filiztekin E, \u00d6zkaya KG. COVID-19 diagnosis-a review of current methods. Biosens Bioelectron. 2021;172: 112752.","journal-title":"Biosens Bioelectron"},{"key":"5315_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/tropicalmed7040059","volume":"7","author":"C Lee","year":"2022","unstructured":"Lee C, Hong SK, Kim JH. An imported case of afebrile Plasmodium falciparum malaria infection from Tanzania in a returning traveler to the Republic of Korea following an earlier COVID-19 infection. Trop Med Infect Dis. 2022;7:59.","journal-title":"Trop Med Infect Dis"},{"key":"5315_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/IDR.S184489","volume":"12","author":"N Awoke","year":"2019","unstructured":"Awoke N, Arota A. Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia. Infect Drug Resist. 2019;12:521\u20137.","journal-title":"Infect Drug Resist"},{"key":"5315_CR34","doi-asserted-by":"publisher","first-page":"5954394","DOI":"10.1155\/2016\/5954394","volume":"2016","author":"M Al-Salahy","year":"2016","unstructured":"Al-Salahy M, Shnawa B, Abed G, Mandour A, Al-Ezzi A. Parasitaemia and its relation to hematological parameters and liver function among patients malaria in Abs, Hajjah, Northwest Yemen. Interdiscip Perspect Infect Dis. 2016;2016:5954394.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"5315_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009766","volume":"15","author":"P Wilairatana","year":"2021","unstructured":"Wilairatana P, Masangkay FR, Kotepui KU, Milanez GJ, Kotepui M. Prevalence and characteristics of malaria among COVID-19 individuals: a systematic review, meta-analysis, and analysis of case reports. PLoS Negl Trop Dis. 2021;15: e0009766.","journal-title":"PLoS Negl Trop Dis"},{"key":"5315_CR36","volume":"8","author":"L De Rop","year":"2024","unstructured":"De Rop L, Bos DA, Stegeman I, Holtman G, Ochodo EA, Spijker R, et al. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2. Cochrane Database Syst Rev. 2024;8: CD015050.","journal-title":"Cochrane Database Syst Rev"},{"key":"5315_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12879-022-07064-4","volume":"22","author":"SA Osei","year":"2022","unstructured":"Osei SA, Biney RP, Anning AS, Nortey LN, Ghartey-Kwansah G. Low incidence of COVID-19 case severity and mortality in Africa; could malaria co-infection provide the missing link? BMC Infect Dis. 2022;22:78.","journal-title":"BMC Infect Dis"},{"key":"5315_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","volume":"95","author":"DF Lelis","year":"2019","unstructured":"Lelis DF, Freitas DF, Machado AS, Crespo TS, Santos SHS. Angiotensin-(1\u20137), adipokines and inflammation. Metabolism. 2019;95:36\u201345.","journal-title":"Metabolism"},{"key":"5315_CR39","doi-asserted-by":"publisher","first-page":"17146","DOI":"10.1038\/s41598-021-96462-w","volume":"11","author":"G Sun","year":"2021","unstructured":"Sun G, Cui Q, Garcia G Jr, Wang C, Zhang M, Arumugaswami V, et al. Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses. Sci Rep. 2021;11:17146.","journal-title":"Sci Rep"},{"key":"5315_CR40","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s13577-021-00489-0","volume":"34","author":"A De","year":"2021","unstructured":"De A, Tiwari A, Dash M, Sinha A. ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas. Hum Cell. 2021;34:702\u20135.","journal-title":"Hum Cell"},{"key":"5315_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","volume":"251","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251:228\u201348.","journal-title":"J Pathol"},{"key":"5315_CR42","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/jmv.26826","volume":"93","author":"S Khanmohammadi","year":"2021","unstructured":"Khanmohammadi S, Rezaei N. Role of toll-like receptors in the pathogenesis of COVID-19. J Med Virol. 2021;93:2735\u20139.","journal-title":"J Med Virol"},{"key":"5315_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09318","volume":"8","author":"AD Ramirez Ramirez","year":"2022","unstructured":"Ramirez Ramirez AD, de Jesus MCS, Rossit J, Reis NF, Santos-Filho MC, Sudr\u00e9 AP, et al. Association of toll-like receptors in malaria susceptibility and immunopathogenesis: a meta-analysis. Heliyon. 2022;8: e09318.","journal-title":"Heliyon"},{"key":"5315_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.650231","volume":"8","author":"M Rusmini","year":"2021","unstructured":"Rusmini M, Uva P, Amoroso A, Tolomeo M, Cavalli A. How genetics might explain the unusual link between malaria and COVID-19. Front Med (Lausanne). 2021;8: 650231.","journal-title":"Front Med (Lausanne)"},{"key":"5315_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103161","volume":"21","author":"J Song","year":"2022","unstructured":"Song J, Li M, Li C, Liu K, Zhu Y, Zhang H. Friend or foe: RIG- I like receptors and diseases. Autoimmun Rev. 2022;21: 103161.","journal-title":"Autoimmun Rev"},{"key":"5315_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114533","volume":"43","author":"K Tapela","year":"2024","unstructured":"Tapela K, Prah DA, Tetteh B, Nuokpem F, Dosoo D, Coker A, et al. Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria. Cell Rep. 2024;43: 114533.","journal-title":"Cell Rep"},{"key":"5315_CR47","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3389\/fimmu.2020.01870","volume":"11","author":"M Herrmann","year":"2020","unstructured":"Herrmann M, Schulte S, Wildner NH, Wittner M, Brehm TT, Ramharter M, et al. Analysis of co-inhibitory receptor expression in COVID-19 infection compared to acute Plasmodium falciparum malaria: LAG-3 and TIM-3 correlate with T cell activation and course of disease. Front Immunol. 2020;11:1870.","journal-title":"Front Immunol"},{"key":"5315_CR48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/JLB.5COVA0620-370RR","volume":"109","author":"NH Wildner","year":"2021","unstructured":"Wildner NH, Ahmadi P, Schulte S, Brauneck F, Kohsar M, L\u00fctgehetmann M, et al. B cell analysis in SARS-CoV-2 versus malaria: increased frequencies of plasmablasts and atypical memory B cells in COVID-19. J Leukoc Biol. 2021;109:77\u201390.","journal-title":"J Leukoc Biol"},{"key":"5315_CR49","doi-asserted-by":"crossref","unstructured":"Briggs J, Takahashi S, Nayebare P, Cuu G, Rek J, Zedi M, et al. Reconstructing the SARS-CoV-2 epidemic in eastern Uganda through longitudinal serosurveillance in a malaria cohort. medRxiv. 2022. (pre-print).","DOI":"10.1101\/2022.09.20.22280170"},{"key":"5315_CR50","doi-asserted-by":"publisher","first-page":"1307553","DOI":"10.3389\/fcimb.2023.1307553","volume":"13","author":"A Fraga","year":"2023","unstructured":"Fraga A, M\u00f3sca AF, Moita D, Simas JP, Nunes-Caba\u00e7o H, Prud\u00eancio M. SARS-CoV-2 decreases malaria severity in co-infected rodent models. Front Cell Infect Microbiol. 2023;13:1307553.","journal-title":"Front Cell Infect Microbiol"},{"key":"5315_CR51","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1172\/JCI142804","volume":"130","author":"M Secchi","year":"2020","unstructured":"Secchi M, Bazzigaluppi E, Brigatti C, Marzinotto I, Tresoldi C, Rovere-Querini P, et al. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020;130:6366\u201378.","journal-title":"J Clin Invest"},{"key":"5315_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10390","volume":"8","author":"J Abugri","year":"2022","unstructured":"Abugri J, Ayariga J, Sunwiale SS, Wezena CA, Gyamfi JA, Adu-Frimpong M, et al. Targeting the Plasmodium falciparum proteome and organelles for potential antimalarial drug candidates. Heliyon. 2022;8: e10390.","journal-title":"Heliyon"},{"key":"5315_CR53","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s12879-022-07820-6","volume":"22","author":"E Lyimo","year":"2022","unstructured":"Lyimo E, Fougeroux C, Malabeja A, Mbwana J, Hayuma PM, Liheluka E, et al. Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021. BMC Infect Dis. 2022;22:846.","journal-title":"BMC Infect Dis"},{"key":"5315_CR54","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3201\/eid2805.220404","volume":"28","author":"JT Grassia","year":"2022","unstructured":"Grassia JT, Markwalter CF, O\u2019Meara WP, Taylor SM, Obala AA. SARS-CoV-2 Cross-reactivity in prepandemic serum from rural malaria-infected persons, Cambodia. Emerg Infect Dis. 2022;28:1080\u20131.","journal-title":"Emerg Infect Dis"},{"key":"5315_CR55","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3201\/eid2802.211725","volume":"28","author":"J Manning","year":"2022","unstructured":"Manning J, Zaidi I, Lon C, Rosas LA, Park JK, Ponce A, et al. SARS-CoV-2 cross-reactivity in prepandemic serum from rural malaria-infected persons, Cambodia. Emerg Infect Dis. 2022;28:440\u20134.","journal-title":"Emerg Infect Dis"},{"key":"5315_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12936-024-05081-z","volume":"23","author":"E Aninagyei","year":"2024","unstructured":"Aninagyei E, Agbenowoshie PS, Akpalu PM, Asiewe SB, Menu RY, Gbadago F, et al. ABO and Rhesus blood group variability and their associations with clinical malaria presentations. Malar J. 2024;23:257.","journal-title":"Malar J"},{"key":"5315_CR57","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jiph.2023.04.013","volume":"16","author":"AA Saba","year":"2023","unstructured":"Saba AA, Sayem M, Rimon RA, Sanyal M, Chakraborty S, Rahman MA, et al. Evaluating the seroprevalence of SARS-CoV-2 IgG in five different districts of Bangladesh. A seroepidemiological study. J Infect Public Health. 2023;16:964\u201373.","journal-title":"J Infect Public Health"},{"key":"5315_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010910","volume":"19","author":"DH Opi","year":"2023","unstructured":"Opi DH, Ndila CM, Uyoga S, Macharia AW, Fennell C, Ochola LB, et al. Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria. PLoS Genet. 2023;19: e1010910.","journal-title":"PLoS Genet"},{"key":"5315_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0169-4758(94)90400-6","volume":"10","author":"M Wahlgren","year":"1994","unstructured":"Wahlgren M, Fernandez V, Scholander C, Carlson J. Rosetting. Parasitol Today. 1994;10:73\u20139.","journal-title":"Parasitol Today"},{"key":"5315_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182019001288","volume":"147","author":"F McQuaid","year":"2020","unstructured":"McQuaid F, Rowe JA. Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting. Parasitology. 2020;147:1\u201311.","journal-title":"Parasitology"},{"key":"5315_CR61","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255\u201373.","journal-title":"N Engl J Med"},{"key":"5315_CR62","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and functional exhaustion of T cells in patients with Coronavirus disease 2019 (COVID-19). Front Immunol. 2020;11:827.","journal-title":"Front Immunol"},{"key":"5315_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30:1\u20139.","journal-title":"Rev Med Virol"},{"key":"5315_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/pathogens11020195","volume":"11","author":"C Halim","year":"2022","unstructured":"Halim C, Mirza AF, Sari MI. The association between TNF-\u03b1, IL-6, and Vitamin D levels and COVID-19 severity and mortality: a systematic review and meta-analysis. Pathogens. 2022;11:195.","journal-title":"Pathogens"},{"key":"5315_CR65","doi-asserted-by":"publisher","first-page":"1077236","DOI":"10.3389\/fimmu.2023.1077236","volume":"14","author":"H Nasrollahi","year":"2023","unstructured":"Nasrollahi H, Talepoor AG, Saleh Z, Eshkevar Vakili M, Heydarinezhad P, Karami N, et al. Immune responses in mildly versus critically ill COVID-19 patients. Front Immunol. 2023;14:1077236.","journal-title":"Front Immunol"},{"key":"5315_CR66","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1473-3099(02)00344-4","volume":"2","author":"L Malaguarnera","year":"2002","unstructured":"Malaguarnera L, Musumeci S. The immune response to Plasmodium falciparum malaria. Lancet Infect Dis. 2002;2:472\u20138.","journal-title":"Lancet Infect Dis"},{"key":"5315_CR67","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.3389\/fimmu.2019.02398","volume":"10","author":"KM Kimenyi","year":"2019","unstructured":"Kimenyi KM, Wamae K, Ochola-Oyier LI. Understanding P. falciparum asymptomatic infections: a proposition for a transcriptomic approach. Front Immunol. 2019;10:2398.","journal-title":"Front Immunol"},{"key":"5315_CR68","unstructured":"WHO. Global COVID-19 vaccination strategy in a changing world. Geneva: World Health Organization, 2022. https:\/\/www.who.int\/publications\/m\/item\/global-covid-19-vaccination-strategy-in-a-changing-world--july-2022-update. Accessed 17 June 2023."},{"key":"5315_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, et al. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022;7:146.","journal-title":"Signal Transduct Target Ther"},{"key":"5315_CR70","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/ijbs.59233","volume":"17","author":"JW Park","year":"2021","unstructured":"Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci. 2021;17:1446\u201360.","journal-title":"Int J Biol Sci"},{"key":"5315_CR71","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","volume":"16","author":"MB Laurens","year":"2020","unstructured":"Laurens MB. RTS, S\/AS01 vaccine (Mosquirix\u2122): an overview. Hum Vaccin Immunother. 2020;16:480\u20139.","journal-title":"Hum Vaccin Immunother"},{"key":"5315_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taad140","author":"B Genton","year":"2023","unstructured":"Genton B. R21\/Matrix-M\u2122 malaria vaccine: a new tool to achieve WHO\u2019s goal to eliminate malaria in 30 countries by 2030? J Travel Med. 2023. https:\/\/doi.org\/10.1093\/jtm\/taad140.","journal-title":"J Travel Med"},{"key":"5315_CR73","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00241-21","volume":"36","author":"H You","year":"2023","unstructured":"You H, Jones MK, Gordon CA, Arganda AE, Cai P, Al-Wassiti H, et al. The mRNA vaccine technology era and the future control of parasitic infections. Clin Microbiol Rev. 2023;36: e0024121.","journal-title":"Clin Microbiol Rev"},{"key":"5315_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.649532","volume":"12","author":"FM Uckun","year":"2021","unstructured":"Uckun FM, Saund S, Windlass H, Trieu V. Repurposing anti-malaria phytomedicine artemisinin as a COVID-19 drug. Front Pharmacol. 2021;12: 649532.","journal-title":"Front Pharmacol"},{"key":"5315_CR75","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1021\/acsinfecdis.0c00522","volume":"6","author":"R Cao","year":"2020","unstructured":"Cao R, Hu H, Li Y, Wang X, Xu M, Liu J, et al. Anti-SARS-CoV-2 potential of artemisinins in vitro. ACS Infect Dis. 2020;6:2524\u201331.","journal-title":"ACS Infect Dis"},{"key":"5315_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105127","volume":"193","author":"L Persoons","year":"2021","unstructured":"Persoons L, Vanderlinden E, Vangeel L, Wang X, Do NDT, Foo SC, et al. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Antivir Res. 2021;193: 105127.","journal-title":"Antivir Res"},{"key":"5315_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agent. 2020;56: 105949.","journal-title":"Int J Antimicrob Agent"},{"key":"5315_CR78","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/ph15050634","volume":"15","author":"S Marin","year":"2022","unstructured":"Marin S, Martin Val A, Bosch Peligero M, Rodr\u00edguez-Bernuz C, P\u00e9rez-Ricart A, Vilar\u00f3 Jaques L, et al. Safety of short-term treatments with oral chloroquine and hydroxychloroquine in patients with and without COVID-19: a systematic review. Pharmaceuticals (Basel). 2022;15:634.","journal-title":"Pharmaceuticals (Basel)"},{"key":"5315_CR79","doi-asserted-by":"publisher","first-page":"40817","DOI":"10.1021\/acsomega.3c05900","volume":"8","author":"T Jones","year":"2023","unstructured":"Jones T, Monakhova N, Guivel-Benhassine F, Lepioshkin A, Bruel T, Lane TR, et al. Synthesis and evaluation of 9-aminoacridines with SARS-CoV-2 antiviral activity. ACS Omega. 2023;8:40817\u201322.","journal-title":"ACS Omega"},{"key":"5315_CR80","first-page":"CD014963","volume":"11","author":"C Wagner","year":"2022","unstructured":"Wagner C, Griesel M, Mikolajewska A, Metzendorf MI, Fischer AL, Stegemann M, et al. Systemic corticosteroids for the treatment of COVID-19: equity-related analyses and update on evidence. Cochrane Database Syst Rev. 2022;11:CD014963.","journal-title":"Cochrane Database Syst Rev"},{"key":"5315_CR81","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","volume":"47","author":"D Chaudhuri","year":"2021","unstructured":"Chaudhuri D, Sasaki K, Karkar A, Sharif S, Lewis K, Mammen MJ, et al. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensiv Care Med. 2021;47:521\u201337.","journal-title":"Intensiv Care Med"},{"key":"5315_CR82","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1038\/s41467-018-06986-5","volume":"9","author":"L Vandermosten","year":"2018","unstructured":"Vandermosten L, Pham TT, Knoops S, De Geest C, Lays N, Van der Molen K, et al. Adrenal hormones mediate disease tolerance in malaria. Nat Commun. 2018;9:4525.","journal-title":"Nat Commun"},{"key":"5315_CR83","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12936-020-03476-2","volume":"19","author":"N Castaldo","year":"2020","unstructured":"Castaldo N, Tascini C, Della Siega P, Peghin M, Pecori D. Clinical presentation and immunological features of post-malaria neurologic syndrome: a case report and review of literature. Malar J. 2020;19:419.","journal-title":"Malar J"},{"key":"5315_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114851","volume":"163","author":"D Kwapisz","year":"2023","unstructured":"Kwapisz D, Bogus\u0142awska J. Intravenous immunoglobulins (IVIG) in severe\/critical COVID-19 adult patients. Biomed Pharmacother. 2023;163: 114851.","journal-title":"Biomed Pharmacother"},{"key":"5315_CR85","volume-title":"Intravenous immunoglobulin (IVIG)","author":"VB Arumugham","year":"2023","unstructured":"Arumugham VB, Rayi A. Intravenous immunoglobulin (IVIG). StatPearls: Treasure Island; 2023."},{"key":"5315_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009885","volume":"17","author":"S Kumar","year":"2021","unstructured":"Kumar S, Chandele A, Sharma A. Current status of therapeutic monoclonal antibodies against SARS-CoV-2. PLoS Pathog. 2021;17: e1009885.","journal-title":"PLoS Pathog"},{"key":"5315_CR87","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(22)00163-5","volume":"399","author":"RCGO Abani","year":"2022","unstructured":"Abani RCGO, Abbas A, Abbas F, Abbas M, Abbasi S. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2022;399:665\u201376.","journal-title":"Lancet"},{"key":"5315_CR88","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2021.24939","volume":"327","author":"MP O'Brien","year":"2022","unstructured":"O\u2019Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, et al. Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized clinical trial. JAMA. 2022;327:432\u201341.","journal-title":"JAMA"},{"key":"5315_CR89","unstructured":"WHO. Coronavirus disease (COVID-19): Casirivimab and Imdevimab-monoclonal antibody therapy. Geneva: World Health Organization. 2021. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/question-and-answers-hub\/q-a-detail\/coronavirus-disease-(covid-19)-casirivimab-and-imdevimab---monoclonal-antibody-therapy. Accessed 4 Dec 2023."},{"key":"5315_CR90","doi-asserted-by":"publisher","first-page":"2031483","DOI":"10.1080\/19420862.2022.2031483","volume":"14","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang H, Sun L. Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming? MAbs. 2022;14:2031483.","journal-title":"MAbs"},{"key":"5315_CR91","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","volume":"387","author":"K Kayentao","year":"2022","unstructured":"Kayentao K, Ongoiba A, Preston AC, Healy SA, Doumbo S, Doumtabe D, et al. Safety and efficacy of a monoclonal antibody against malaria in Mali. N Engl J Med. 2022;387:1833\u201342.","journal-title":"N Engl J Med"},{"key":"5315_CR92","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1056\/NEJMoa2203067","volume":"387","author":"RL Wu","year":"2022","unstructured":"Wu RL, Idris AH, Berkowitz NM, Happe M, Gaudinski MR, Buettner C, et al. Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria. N Engl J Med. 2022;387:397\u2013407.","journal-title":"N Engl J Med"},{"key":"5315_CR93","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ymthe.2022.04.001","volume":"30","author":"M Aleshnick","year":"2022","unstructured":"Aleshnick M, Florez-Cuadros M, Martinson T, Wilder BK. Monoclonal antibodies for malaria prevention. Mol Ther. 2022;30:1810\u201321.","journal-title":"Mol Ther"},{"key":"5315_CR94","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.ajem.2020.06.082","volume":"38","author":"S Lentz","year":"2020","unstructured":"Lentz S, Roginski MA, Montrief T, Ramzy M, Gottlieb M, Long B. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS. Am J Emerg Med. 2020;38:2194\u2013202.","journal-title":"Am J Emerg Med"},{"key":"5315_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.646988","volume":"8","author":"V Chaudhari","year":"2021","unstructured":"Chaudhari V, Buttar HS, Bagwe-Parab S, Tuli HS, Vora A, Kaur G. Therapeutic and industrial applications of curdlan with overview on its recent patents. Front Nutr. 2021;8: 646988.","journal-title":"Front Nutr"},{"key":"5315_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.139330","volume":"732","author":"EJ Murphy","year":"2020","unstructured":"Murphy EJ, Masterson C, Rezoagli E, O\u2019Toole D, Major I, Stack GD, et al. \u03b2-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects\u2014implications for coronavirus disease (COVID-19) immunotherapies. Sci Total Environ. 2020;732: 139330.","journal-title":"Sci Total Environ"},{"key":"5315_CR97","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s43450-022-00353-8","volume":"33","author":"H Rashidzadeh","year":"2023","unstructured":"Rashidzadeh H, Mosavi FS, Shafiee T, Adyani SM, Eghlima G, Sanikhani M, et al. Anti-plasmodial effects of different ecotypes of Glycyrrhiza glabra traditionally used for malaria in Iran. Rev Bras Farmacogn. 2023;33:310\u20135.","journal-title":"Rev Bras Farmacogn"},{"key":"5315_CR98","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760210084","volume":"116","author":"MNC Soeiro","year":"2021","unstructured":"Soeiro MNC, Vergoten G, Bailly C. Mechanism of action of glycyrrhizin against Plasmodium falciparum. Mem Inst Oswaldo Cruz. 2021;116: e210084.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5315_CR99","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.3390\/molecules27092841","volume":"27","author":"R Wansri","year":"2022","unstructured":"Wansri R, Lin ACK, Pengon J, Kamchonwongpaisan S, Srimongkolpithak N, Rattanajak R, et al. Semi-synthesis of N-aryl amide analogs of piperine from Piper nigrum and evaluation of their antitrypanosomal, antimalarial, and anti-SARS-CoV-2 main protease activities. Molecules. 2022;27:2841.","journal-title":"Molecules"},{"key":"5315_CR100","first-page":"1014","volume":"24","author":"M Tania","year":"2021","unstructured":"Tania M, Asad A, Li T, Islam MS, Islam SB, Hossen MM, et al. Thymoquinone against infectious diseases: perspectives in recent pandemics and future therapeutics. Iran J Basic Med Sci. 2021;24:1014\u201322.","journal-title":"Iran J Basic Med Sci"},{"key":"5315_CR101","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1142\/S0192415X20500512","volume":"48","author":"LLD Zhong","year":"2020","unstructured":"Zhong LLD, Lam WC, Yang W, Chan KW, Sze SCW, Miao J, et al. Potential targets for treatment of Coronavirus Disease 2019 (COVID-19): a review of Qing-Fei-Pai-Du-Tang and its major herbs. Am J Chin Med. 2020;48:1051\u201371.","journal-title":"Am J Chin Med"},{"key":"5315_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945583","volume":"13","author":"ZA Rizvi","year":"2022","unstructured":"Rizvi ZA, Babele P, Sadhu S, Madan U, Tripathy MR, Goswami S, et al. Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis. Front Immunol. 2022;13: 945583.","journal-title":"Front Immunol"},{"key":"5315_CR103","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1182\/blood-2005-07-2705","volume":"107","author":"DE Cramer","year":"2006","unstructured":"Cramer DE, Allendorf DJ, Baran JT, Hansen R, Marroquin J, Li B, et al. Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood. 2006;107:835\u201340.","journal-title":"Blood"},{"key":"5315_CR104","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1021\/acsnano.3c02303","volume":"17","author":"Z Wang","year":"2023","unstructured":"Wang Z, Jin A, Yang Z, Huang W. Advanced nitric oxide generating nanomedicine for therapeutic applications. ACS Nano. 2023;17:8935\u201365.","journal-title":"ACS Nano"},{"key":"5315_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.603037","volume":"7","author":"AAA Abdusalam","year":"2020","unstructured":"Abdusalam AAA, Murugaiyah V. Identification of potential inhibitors of 3CL protease of SARS-CoV-2 from ZINC database by molecular docking-based virtual screening. Front Mol Biosci. 2020;7: 603037.","journal-title":"Front Mol Biosci"},{"key":"5315_CR106","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.3390\/ijms24044237","volume":"24","author":"JX Shen","year":"2023","unstructured":"Shen JX, Du WW, Xia YL, Zhang ZB, Yu ZF, Fu YX, et al. Identification of and mechanistic insights into SARS-CoV-2 main protease non-covalent inhibitors: an in-silico study. Int J Mol Sci. 2023;24:4237.","journal-title":"Int J Mol Sci"},{"key":"5315_CR107","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12936-023-04452-2","volume":"22","author":"J Park","year":"2023","unstructured":"Park J, Kang S, Seok D, Baek YJ, An SY, Lee J, et al. Barriers against and strategies for malaria control during the COVID-19 pandemic in low- and middle-income countries: a systematic review. Malar J. 2023;22:41.","journal-title":"Malar J"},{"key":"5315_CR108","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10142-023-01072-6","volume":"23","author":"M Yadav","year":"2023","unstructured":"Yadav M, Dahiya N, Sehrawat N. Mosquito gene targeted RNAi studies for vector control. Funct Integr Genom. 2023;23:180.","journal-title":"Funct Integr Genom"},{"key":"5315_CR109","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12936-014-0526-x","volume":"14","author":"RL Heinig","year":"2015","unstructured":"Heinig RL, Thomas MB. Interactions between a fungal entomopathogen and malaria parasites within a mosquito vector. Malar J. 2015;14:22.","journal-title":"Malar J"},{"key":"5315_CR110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.actatropica.2011.11.001","volume":"121","author":"R Abdul-Ghani","year":"2012","unstructured":"Abdul-Ghani R, Al-Mekhlafi AM, Alabsi MS. Microbial control of malaria: biological warfare against the parasite and its vector. Acta Trop. 2012;121:71\u201384.","journal-title":"Acta Trop"},{"key":"5315_CR111","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12936-022-04273-9","volume":"21","author":"M Zhu","year":"2022","unstructured":"Zhu M, Zhang C, Zhang Y, Wang Z, Ma X, Dai S, et al. An epidemiological analysis of imported malaria in Shanghai during a COVID-19 outbreak. Malar J. 2022;21:245.","journal-title":"Malar J"},{"key":"5315_CR112","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00430-023-00774-9","volume":"212","author":"A Osterman","year":"2023","unstructured":"Osterman A, Krenn F, Iglhaut M, Badell I, Lehner A, Sp\u00e4th PM, et al. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages. Med Microbiol Immunol. 2023;212:307\u201322.","journal-title":"Med Microbiol Immunol"},{"key":"5315_CR113","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.3201\/eid2813.220711","volume":"28","author":"C Kinkade","year":"2022","unstructured":"Kinkade C, Russpatrick S, Potter R, Saebo J, Sloan M, Odongo G, et al. Extending and strengthening routine DHIS2 surveillance systems for COVID-19 responses in Sierra Leone, Sri Lanka, and Uganda. Emerg Infect Dis. 2022;28:S42-s48.","journal-title":"Emerg Infect Dis"},{"key":"5315_CR114","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.3201\/eid2813.220898","volume":"28","author":"DC Shih","year":"2022","unstructured":"Shih DC, Silver R, Henao OL, Alemu A, Audi A, Bigogo G, et al. Incorporating COVID-19 into acute febrile illness surveillance systems, Belize, Kenya, Ethiopia, Peru, and Liberia, 2020\u20132021. Emerg Infect Dis. 2022;28:S34-s41.","journal-title":"Emerg Infect Dis"},{"key":"5315_CR115","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12936-020-03465-5","volume":"19","author":"P Ranaweera","year":"2020","unstructured":"Ranaweera P, Wickremasinghe R, Mendis K. Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic. Malar J. 2020;19:386.","journal-title":"Malar J"},{"key":"5315_CR116","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.70013","volume":"12","author":"C Nkansah","year":"2024","unstructured":"Nkansah C, Osei-Boakye F, Abbam G, Appiah SK, Daud S, Boakye B, et al. Pro- and anti-inflammatory cytokines mediate the progression of severe anemia in malaria-infected children: a prospective study. Immun Inflamm Dis. 2024;12: e70013.","journal-title":"Immun Inflamm Dis"},{"key":"5315_CR117","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250\u20136.","journal-title":"J Med Virol"},{"key":"5315_CR118","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.3390\/ijms252111411","volume":"25","author":"TG Paranga","year":"2024","unstructured":"Paranga TG, Mitu I, Pavel-Tanasa M, Rosu MF, Miftode IL, Constantinescu D, et al. Cytokine storm in COVID-19: exploring IL-6 signaling and cytokine-microbiome interactions as emerging therapeutic approaches. Int J Mol Sci. 2024;25:11411.","journal-title":"Int J Mol Sci"},{"key":"5315_CR119","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12906-016-1207-9","volume":"16","author":"MA Mubaraki","year":"2016","unstructured":"Mubaraki MA, Hafiz TA, Dkhil MA, Al-Quraishy S. Beneficial effect of Punica granatum peel extract on murine malaria-induced spleen injury. BMC Complement Altern Med. 2016;16:221.","journal-title":"BMC Complement Altern Med"},{"key":"5315_CR120","doi-asserted-by":"publisher","first-page":"113256","DOI":"10.1016\/j.biopha.2022.113256","volume":"153","author":"N Maphetu","year":"2022","unstructured":"Maphetu N, Unuofin JO, Masuku NP, Olisah C, Lebelo SL. Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: a review. Biomed Pharmacother. 2022;153:113256.","journal-title":"Biomed Pharmacother"},{"key":"5315_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105145","volume":"114","author":"R Suru\u010di\u0107","year":"2021","unstructured":"Suru\u010di\u0107 R, Travar M, Petkovi\u0107 M, Tubi\u0107 B, Stojiljkovi\u0107 MP, Grabe\u017e M, et al. Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 receptor: in silico and in vitro studies. Bioorg Chem. 2021;114: 105145.","journal-title":"Bioorg Chem"},{"key":"5315_CR122","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3390\/microorganisms9050893","volume":"9","author":"K Zandi","year":"2021","unstructured":"Zandi K, Musall K, Oo A, Cao D, Liang B, Hassandarvish P, et al. Baicalein and Baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase. Microorganisms. 2021;9:893.","journal-title":"Microorganisms"},{"key":"5315_CR123","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5455\/medarh.2022.76.419-425","volume":"76","author":"T Makmur","year":"2022","unstructured":"Makmur T, Siregar FA, Siregar S, Lubis IA, Bestari R, Zein U. Open clinical trial of Sambiloto (Andrographis paniculata) ethanolic extract capsules in treatment of malaria patients in Batubara District, Indonesia. Med Arch. 2022;76:419\u201325.","journal-title":"Med Arch"},{"key":"5315_CR124","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1021\/acs.jnatprod.0c01324","volume":"84","author":"K Sa-Ngiamsuntorn","year":"2021","unstructured":"Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y, Thongsri P, Kanjanasirirat P, Manopwisedjaroen S, et al. Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. J Nat Prod. 2021;84:1261\u201370.","journal-title":"J Nat Prod"},{"key":"5315_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2022.100398","volume":"3","author":"K Shanker","year":"2023","unstructured":"Shanker K, Rangnekar H, Wele A, Soni P, Gaikwad P, Pal A, et al. A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19. Phytomed Plus. 2023;3: 100398.","journal-title":"Phytomed Plus"},{"key":"5315_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275181","volume":"17","author":"F Buder","year":"2022","unstructured":"Buder F, Selejan SR, Hohl M, Kindermann M, Herr C, Lepper PM, et al. Glycyrrhizin through liquorice intake modulates ACE2 and HMGB1 levels-a pilot study in healthy individuals with implications for COVID-19 and ARDS. PLoS ONE. 2022;17: e0275181.","journal-title":"PLoS ONE"},{"key":"5315_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107232","volume":"90","author":"A Kivrak","year":"2021","unstructured":"Kivrak A, Ula\u015f B, Kivrak H. A comparative analysis for anti-viral drugs: their efficiency against SARS-CoV-2. Int Immunopharmacol. 2021;90: 107232.","journal-title":"Int Immunopharmacol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05315-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05315-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T04:11:55Z","timestamp":1743307915000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05315-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5315"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05315-8","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}